Minimal Residual Disease (MRD) Monitoring: The Impact of Diagnostic...

agregó una foto Health

2025-11-21 11:10:45 -

Minimal Residual Disease (MRD) Monitoring: The Impact of Diagnostic Precision on Treatment Decisions in the US Leukemia Therapeutics Market

Determining the actual **Market Size** of the **US Leukemia Therapeutics Market** involves a complex interplay between the high average selling prices (ASPs) of novel, patented drugs and the potential volume erosion caused by generic and biosimilar competition. The market size is heavily inflated by the premium pricing commanded by revolutionary therapies like CAR T-cells and next-generation...

0 Commentarios 0 Acciones 213 Views 0 Vista previa